Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Howe who wrote (1439)	11/17/1998 9:07:00 AM
From: BMcV	Read Replies (1) of 10280

SEPR's partner for the dry powder formulations of its asthma drugs links up with the maker of the parent of one of those drugs (formoterol). biz.yahoo.com SkyePharma and Novartis Sign Dry Powder Inhaler Deal - Novartis Makes $10 Million Equity Investment in SkyePharma - Original article on SEPR / Skye agreement: biz.yahoo.com This is interesting for two reasons: it shows SkyePharma has good technology, and it raises the question of a Novartis/Sepracor deal on formoterol.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next